Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
25 avr. 2024 08h05 HE
|
Shareholder Capital LLC
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
18 avr. 2019 06h30 HE
|
Bragar Eagel & Squire
NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
11 avr. 2019 06h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
04 avr. 2019 06h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, AVEO Pharmaceuticals, Stamps.com, and Syneos and Encourages Investors to Contact the Firm
28 mars 2019 07h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact the Firm
03 mars 2019 18h20 HE
|
Bragar Eagel & Squire
NEW YORK, March 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Diplomat Pharmacy, Inc.,...
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA) and Encourages VNDA Investors to Contact the Firm
25 févr. 2019 20h16 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on...
Bragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm
21 févr. 2019 20h44 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). Our investigation concerns whether...
Bragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm
11 févr. 2019 15h12 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). Our investigation concerns whether...